Related references
Note: Only part of the references are listed.Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Dihydropyrimidine Accumulation Is Required for the Epithelial-Mesenchymal Transition
Yoav D. Shaul et al.
CELL (2014)
Neural crest stem cells in melanoma development
Olga Shakhova
CURRENT OPINION IN ONCOLOGY (2014)
Ezh2 is required for neural crest-derived cartilage and bone formation
Daniel Schwarz et al.
DEVELOPMENT (2014)
Why is melanoma so metastatic?
Russell R. Braeuer et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
EZH2 expands breast stem cells through activation of NOTCH1 signaling
Maria E. Gonzalez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
BRAF Inhibitors Induce Metastasis in RAS Mutant or Inhibitor-Resistant Melanoma Cells By Reactivating MEK and ERK Signaling
Berta Sanchez-Laorden et al.
SCIENCE SIGNALING (2014)
Directed Phenotype Switching as an Effective Antimelanoma Strategy
Magali Saez-Ayala et al.
CANCER CELL (2013)
A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma
Julie Caramel et al.
CANCER CELL (2013)
EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
Wendy Beguelin et al.
CANCER CELL (2013)
Sox4 Is a Master Regulator of Epithelial-Mesenchymal Transition by Controlling Ezh2 Expression and Epigenetic Reprogramming
Neha Tiwari et al.
CANCER CELL (2013)
MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2
Chonglin Luo et al.
CANCER LETTERS (2013)
Testing the cancer stem cell hypothesis in melanoma: The clinics will tell
Olga Shakhova et al.
CANCER LETTERS (2013)
Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
Marieta Caganova et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
miR-137 Inhibits the Invasion of Melanoma Cells through Downregulation of Multiple Oncogenic Target Genes
Chonglin Luo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Chromatin proteins and modifications as drug targets
Kristian Helin et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Tumor adaptation and resistance to RAF inhibitors
Piro Lito et al.
NATURE MEDICINE (2013)
A Dual Role for SOX10 in the Maintenance of the Postnatal Melanocyte Lineage and the Differentiation of Melanocyte Stem Cell Progenitors
Melissa L. Harris et al.
PLOS GENETICS (2013)
Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia
Satomi Tanaka et al.
BLOOD (2012)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
Neural crest delamination and migration: From epithelium-to-mesenchyme transition to collective cell migration
Eric Theveneau et al.
DEVELOPMENTAL BIOLOGY (2012)
Neural crest progenitors and stem cells: From early development to adulthood
Elisabeth Dupin et al.
DEVELOPMENTAL BIOLOGY (2012)
Epigenetic alterations in hematopoietic malignancies
Young Rock Chung et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
A tumour suppressor network relying on the polyamine-hypusine axis
Claudio Scuoppo et al.
NATURE (2012)
Sox 10 promotes the formation and maintenance of giant congenital naevi and melanoma
Olga Shakhova et al.
NATURE CELL BIOLOGY (2012)
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Michael Krauthammer et al.
NATURE GENETICS (2012)
Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)
Michael T. McCabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Molecular architecture of human polycomb repressive complex 2
Claudio Ciferri et al.
ELIFE (2012)
β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas
William E. Damsky et al.
CANCER CELL (2011)
Coordinated Activation of Wnt in Epithelial and Melanocyte Stem Cells Initiates Pigmented Hair Regeneration
Piul Rabbani et al.
CELL (2011)
EZH2-Dependent Suppression of a Cellular Senescence Phenotype in Melanoma Cells by Inhibition of p21/CDKN1A Expression
Tao Fan et al.
MOLECULAR CANCER RESEARCH (2011)
The Polycomb complex PRC2 and its mark in life
Raphael Margueron et al.
NATURE (2011)
A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status
Marie C. Zipser et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Functional significance of eIF5A and its hypusine modification in eukaryotes
M. H. Park et al.
AMINO ACIDS (2010)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
Martin Sauvageau et al.
CELL STEM CELL (2010)
An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB
Junxia Min et al.
NATURE MEDICINE (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Targeted Overexpression of EZH2 in the Mammary Gland Disrupts Ductal Morphogenesis and Causes Epithelial Hyperplasia
Xin Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Stage-Specific Control of Neural Crest Stem Cell Proliferation by the Small Rho GTPases Cdc42 and Rac1
Sebastian Fuchs et al.
CELL STEM CELL (2009)
Polycomb Limits the Neurogenic Competence of Neural Precursor Cells to Promote Astrogenic Fate Transition
Yusuke Hirabayashi et al.
NEURON (2009)
WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence
Biaoyang Lin et al.
CLINICAL CANCER RESEARCH (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Expression of polycomb group protein EZH2 in nevi and melanoma
Jonathan B. McHugh et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
Melanoma invasion - current knowledge and future directions
Cedric Gaggioli et al.
PIGMENT CELL RESEARCH (2007)
Stability and flexibility of epigenetic gene regulation in mammalian development
Wolf Reik
NATURE (2007)
Caenorhabditis elegans DYF-2, an orthologue of human WDR19, is a component of the intraflagellar transport machinery in sensory Cilia
Evgeni Efimenko et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Characterization of melanocyte-specific inducible Cre recombinase transgenic mice
M Bosenberg et al.
GENESIS (2006)
The polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion
LM Kamminga et al.
BLOOD (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
CellProfiler: image analysis software for identifying and quantifying cell phenotypes
Anne E. Carpenter et al.
GENOME BIOLOGY (2006)
Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background
J Ackermann et al.
CANCER RESEARCH (2005)
SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells
J Kim et al.
NEURON (2003)
Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement
IH Su et al.
NATURE IMMUNOLOGY (2003)
MethPrimer: designing primers for methylation PCRs
LC Li et al.
BIOINFORMATICS (2002)
Dominant role of the niche in melanocyte stem-cell fate determination
EK Nishimura et al.
NATURE (2002)
Share Paper
